US 7,470,240 · Application 11/122,154 · Granted Dec 30, 2008
US 7,470,240
Pressure pulse/shock wave therapy methods and an apparatus for conducting the therapeutic methods
Estimated expiration
November 5, 2025
Expired 343 days ago
Earliest effective filing
Mar 4, 2005
+ 20 years
Mar 4, 2025
PTA +246d
Nov 5, 2025
No TD
—
Final
Nov 5, 2025
This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.
Calculation details
Base term
- Filing date
- May 4, 2005
- Earliest effective filing
- March 4, 2005
- Issue date
- December 30, 2008
- PTA
- +246 days
- Base expiry (before PTA)
- March 4, 2025
March 4, 2005 + 20 years = March 4, 2025 + 246 PTA days = November 5, 2025
- Continuation-in-part of application 11/071,156, filed Mar 4, 2005
- PRO60/621,028 — Provisional — not used for base term
- PRO60/642,149 — Provisional — not used for base term
- PRO60/621,028 — Provisional — not used for base term
- PRO60/642,149 — Provisional — not used for base term
Terminal disclaimers
Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated
The prosecution record for your AI
Application 11/122,154 · US 7,470,240
You have the date. Your AI can have the file.
PatentReply compiles the prosecution history behind US 7,470,240: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.
One new public application a month is free. The first compile takes a few minutes.
Strategy and filing changes require your approval.
Permanent link
www.patentreply.ai/tools/patent-expiration/US7470240Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.